This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Do you own shares of Hi-Tech Pharmacal Co., Inc. (NASDAQ GS: HITK)?
Did you purchase any of your shares prior to August 27, 2013?
Do you think the proposed buyout price is too low?
Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Hi-Tech Pharmacal Co., Inc. (“Hi-Tech” or the “Company”) (NASDAQ GS:
HITK) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Akorn, Inc. (“Akorn”) (NASDAQ GS:
AKRX) in a transaction valued at approximately $640 million.